[CAS NO. 35899-54-8]  SIBA

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [35899-54-8]

Catalog
HY-18684
Brand
MCE
CAS
35899-54-8

DESCRIPTION [35899-54-8]

Overview

MDLMFCD00056008
Molecular Weight339.41
Molecular FormulaC14H21N5O3S
SMILESO[C@@H]([C@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)O)[C@H]3CSCC(C)C

For research use only. We do not sell to patients.

Summary

SIBA (5'-Isobutylthioadenosine) is a transmethylation inhibitor ( SAH (HY-19528) analogue), with potent anti-proliferative activity. SIBA reversibly inhibits the production of HSV-1 by blocking methylation, specifically by blocking the 5' end-capping of viral mRNA. SIBA also inhibits the growth of tumour cells in vitro and metastatic spread in vivo. SIBA can be used in cancer , HSV-1 infection and anti-malaria studies [1] [2] [3] .


IC50 & Target

Plasmodium

HSV-1


In Vitro

SIBA (0.5 mM; 24-96 h) shows strong anti-proliferative activity against 3LL and RMS-J1 tumour cells [1] .
SIBA (1 mM; 12, 24 h) reversibly inhibits HSV production in HEp2 cells (infected by HSV-1) [2] .
SIBA inhibits protein synthesis by 98% after 10 h infection of HEp2 cells (infected by HSV-1) [2] .
SIBA (1 mM; 8.5 h) inhibits protein synthesis and RNA methylation in HEp2 cells (infected by HSV-1) [2] .
SIBA (0.5, 1.0 mM; 24, 48 h) inhibits the conversion of putrescine into spermidine and/or spermine and that this inhibition is a reversible one (interferes with polyamine biosynthesis, probably by blocking aminopropyltransferase) [3] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay [1]

Cell Line: 3 LL and RMS-J1 cells
Concentration: 0.5 mM
Incubation Time: 24-96 h
Result: Inhibited 3LL and RMS-J1 tumor cell growth potently by 96% and 88%, respectively.

Cell Viability Assay [2]

Cell Line: HEp2 cells (infected by HSV-1)
Concentration: 1 mM
Incubation Time: 12, 24 h
Result: Decreased virus production by 88.4 and 98.2% when at 12 and 24 h, respectively.

Cell Viability Assay [2]

Cell Line: HEp2 cells (infected by HSV-1)
Concentration: 1 mM
Incubation Time: 8.5 h
Result: Reduced protein synthesis by 41.3% in normal medium and by 63.5% in medium poor in methionine.
Inhibited RNA methylation by 65.4%.

Cell Viability Assay [3]

Cell Line: chick embryo fibroblasts
Concentration: 0.5, 1.0 mM
Incubation Time: 24, 48 h
Result: Inhibited the uptake of the radioactive diamine and that the inhibition was dose-dependent.
Markedly inhibited the formation of [ 14 C]spermidine and [ 14 C]spermine from [ 14 C]putrescine.
Inhibited the growth of chick embryo fibroblasts mainly after exposure for 48 h.

In Vivo

SIBA (150 mg/kg; i.p.; twice weekly for 3 weeks) inhibits tumor growth in vivo [1] .
SIBA (15 mg/kg; i.p.; thrice weekly for 4 weeks) inhibits metastatic spread of RMS-J1 cells in vivo [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6 female mice (4-8 weeks old) [1] .
Dosage: 150 mg/kg
Administration: Intraperitoneal injection; twice weekly for 3 weeks.
Result: Significantly reduced the median number of lung metastases.
Animal Model: Adult syngeneic Wistar AG rats (8-week-old; subcutaneously grafted with RMS-J1 cells) [1] .
Dosage: 15 mg/kg
Administration: Intraperitoneal injection; thrice weekly for 4 weeks.
Result: Inhibited in vivo metastatic spread of RMS-J1 cells, and showed median numbers of lung metastatic nodules was 26.

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month

Solvent & Solubility

In Vitro:

DMSO : ≥ 100 mg/mL ( 294.63 mM )

* "≥" means soluble, but saturation unknown.

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.9463 mL 14.7314 mL 29.4629 mL
5 mM 0.5893 mL 2.9463 mL 5.8926 mL
10 mM 0.2946 mL 1.4731 mL 2.9463 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: ≥ 2.5 mg/mL (7.37 mM); Clear solution

  • 2.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.5 mg/mL (7.37 mM); Clear solution

  • 3.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: ≥ 2.5 mg/mL (7.37 mM); Clear solution

* All of the co-solvents are available by MCE.